Page last updated: 2024-08-24

goralatide and Myocardial Ischemia

goralatide has been researched along with Myocardial Ischemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lipsic, E; Schoemaker, RG; van de Wal, RM; van der Meer, P; van Gilst, WH; van Veldhuisen, DJ; Vellenga, E; Voors, AA; Westenbrink, BD	1

Other Studies

1 other study(ies) available for goralatide and Myocardial Ischemia

Article	Year
Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation, 2005, Sep-20, Volume: 112, Issue:12 Topics: Aged; Anemia; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Echocardiography; Female; Glomerular Filtration Rate; Growth Inhibitors; Heart Failure; Hematopoiesis; Humans; Male; Myocardial Ischemia; Oligopeptides; Peptidyl-Dipeptidase A; Reference Values; Ventricular Function, Left	2005

Article

Year

Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.

Circulation, 2005, Sep-20, Volume: 112, Issue:12

Topics: Aged; Anemia; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Echocardiography; Female; Glomerular Filtration Rate; Growth Inhibitors; Heart Failure; Hematopoiesis; Humans; Male; Myocardial Ischemia; Oligopeptides; Peptidyl-Dipeptidase A; Reference Values; Ventricular Function, Left

2005